Brain
IRB #H-29993/RTOG #R0929: A Randomized Phase I/II Study of ABT-888 in Combination with Temozolomide in Recurrent (Temozolomide Resistant) Glioblastoma (Bevacizumab-naïve group temporarily closed to accrual, Bevacizumab-failure group permanently closed to accrual)
